ECFCs were characterized by flowcytometry and the average expression of endothelial markers CD31, CD146 and KDR were 88.8%, 88.2%, 52.2% in case of CAD whereas 87.6%, 89.1% and 57.1% respectively in case of control subjects. The gene discussed is PECAM1; the disease is coronary artery disorder.